Your browser is out of date
With an updated browser, you will have a better Medtronic web site experience. Update my browser now.
It's about time back in your day. It's about time in range. It's about time there was a system that adapts to your unique needs; helping to give you more moments to enjoy the everyday; to navigate your world with convenience. Go beyond multiple daily injections and move forward with your diabetes management.
Focus on your life, not your levels.
The MiniMed™ 770G system automatically adapts to your unique insulin needs every 5 minutes,* helping to give you more time back in your day.
See your glucose levels on your phone and discreetly check them whenever you need. Helps you spend more time in range – and get notified if you're going low or high.
Care partners can check glucose levels remotely from their smartphone any time, any place – so they can be supportive, even when not close by.
The option to use the system as a standalone insulin pump or integrate with 2 levels of continuous glucose monitoring (CGM) – suspend before a predicted low or automatic insulin adjustments.* The choice is yours.
ENABLED FOR FUTURE SOFTWARE UPGRADES
Customers using MiniMed™ 770G system now will have access to our future innovations.
New MiniMed™ 770G system customers will get access to our next technology, when licenced, and available, at no cost through December 31, 2021.†
Here you'll find the resources you need to get started. Getting started is as simple as READY, SET, GO!
LEARN MORECome out and learn about the world’s first self-adjusting insulin pump*
REGISTER TODAYFind diabetes training and education, global assistance, services and more.
SEE SERVICESData on File
Mueckler JR; Chen J; Alford JG; Gopalakrishnan S; Percentage of patients that the system met or exceeded expectations, for the top 3 attributes queried.
Bergenstal, R. M. et al. Jama. 2016; 316 (13): 1407 –1408
Refers to SmartGuard™ auto mode. Some user interaction required. Individual results may vary. **Program subject to change. Program eligibility requirements and terms and conditions apply.
± As of December 7, 2020. The MiniMed™ 770G is indicated for people living with Type 1 diabetes, ages 2 and older. Individual results may vary. ACCU-CHEK, ACCU-CHEK GUIDE is a trademark of Roche Diabetes Care. Edward/Shirin/Mikael are using SmartGuard™ Auto Mode on another Medtronic device.
‡ Garg SK et al. Diabetes Technol Ther. 2017 Mar;19(3):155-163
Terms and conditions and program eligibility requirements apply